Gerd Bader
Impact in
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Chromatin Remodeling and Cancer
- Angiogenesis and VEGF in Cancer
-
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
-
- Natural product bioactivities and synthesis 20
- Protein Degradation and Inhibitors 8
- Biochemical and Molecular Research 3
- Chromatin Remodeling and Cancer 3
- Ubiquitin and proteasome pathways 2
- Co-authors
- Andreas Zoephel (5 shared papers)Pilar Garin‐Chesa (4 shared papers)Jens Quant (3 shared papers)Ulrike Tontsch-Grunt (2 shared papers)Flavio Solca (2 shared papers)Frank Hilberg (1 shared paper)Gerald J. Roth (1 shared paper)Wolfgang Sommergruber (2 shared papers)
- Journals
- Planta Medica (9 papers)Journal of Medicinal Chemistry (5 papers)Molecular Cancer Therapeutics (3 papers)Nature Communications (3 papers)Nature Chemical Biology (3 papers)
- Partner nations
- GermanyAustriaUnited Kingdom
In The Last Decade
Gerd Bader
57 papers receiving 4.3k citations
Gerd Bader's Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 2.2k
- Pulmonary and Respiratory Medicine 957
- Computational Theory and Mathematics 261
- Oncology 339
- Cancer Research 151
Countries citing papers authored by Gerd Bader
This map shows the geographic impact of Gerd Bader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Bader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Bader more than expected).
Fields of papers citing papers by Gerd Bader
This network shows the impact of papers produced by Gerd Bader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Bader. The network helps show where Gerd Bader may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerd Bader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy Hit paper breakdown → | 2008 | 923 |
| 2 | Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker Hit paper breakdown → | 2012 | 753 |
| 3 | BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design Hit paper breakdown → | 2019 | 463 |
| 4 | 2016 | 195 | |
| 5 | 2022 | 183 | |
| 6 | 2017 | 172 | |
| 7 | 2016 | 155 | |
| 8 | 2019 | 130 | |
| 9 | 2000 | 120 | |
| 10 | 2019 | 117 | |
| 11 | 2019 | 116 | |
| 12 | 2001 | 103 | |
| 13 | 2000 | 89 | |
| 14 | 2016 | 76 | |
| 15 | 2020 | 76 | |
| 16 | 2003 | 66 | |
| 17 | 2019 | 65 | |
| 18 | 2018 | 54 | |
| 19 | 2021 | 52 | |
| 20 | 2003 | 46 |
About Gerd Bader
Gerd Bader is a scholar working on Molecular Biology, Physical and Theoretical Chemistry, Cancer Research, Spectroscopy and Pathology and Forensic Medicine, having authored 58 papers that have together received 4.4k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (20 papers), Protein Degradation and Inhibitors (8 papers), Phytochemistry and Biological Activities (3 papers), Biochemical and Molecular Research (3 papers), Enzyme Structure and Function (3 papers), Chromatin Remodeling and Cancer (3 papers), Lung Cancer Treatments and Mutations (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Pulmonary and Respiratory Medicine (957 citations), Computational Theory and Mathematics (261 citations), Oncology (339 citations) and Cancer Research (151 citations). Gerd Bader has collaborated with scholars based in Germany, Austria and United Kingdom. Frequent co-authors include Andreas Zoephel, Pilar Garin‐Chesa, Jens Quant, Ulrike Tontsch-Grunt, Flavio Solca, Frank Hilberg, Gerald J. Roth, Wolfgang Sommergruber, Martin Krššák and Armin Heckel. Their work appears in journals such as Planta Medica, Journal of Medicinal Chemistry, Molecular Cancer Therapeutics, Nature Communications and Nature Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.